Taken together, leonurine exerts significant anti-leukemia efficacy in CML by regulating miR-18a-5p/SOCS5/JAK2/STAT3 axis. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.